WHO-CHOICE Interventions
Breast cancer
| CODE | DESCRIPTION | COVERAGE |
| BRC-1 | Stage I treatment: Lumpectomy with auxiliary dissection + radiotherapy to the breast + endocrine therapy where applicable | 50% |
| BRC-2 | Stage II treatment: Lumpectomy with auxiliary dissection + radiotherapy to the breast + endocrine therapy where applicable | 50% |
| BRC-3 | Stage III treatment: Neo-adjuvant chemotherapy + mastectomy with auxiliary dissection + adjuvant chemotherapy + endocrine therapy where applicable | 50% |
| BRC-4 | Stage IV treatment: Systemic chemotherapy + endocrine therapy for eligible patients | 50% |
| BRC-5 | Treatment all stages | 50% |
| BRC-6 | Optimal program: treatment of all stages plus a breast awareness program and early case finding through biannual mammographic screening in women age 50–70 years. | 50% |
| BRC-7 | Stage I treatment: Lumpectomy with auxiliary dissection + radiotherapy to the breast + endocrine therapy where applicable | 80% |
| BRC-8 | Stage II treatment: Lumpectomy with auxiliary dissection + radiotherapy to the breast + endocrine therapy where applicable | 80% |
| BRC-9 | Stage III treatment: Neo-adjuvant chemotherapy + mastectomy with auxiliary dissection + adjuvant chemotherapy + endocrine therapy where applicable | 80% |
| BRC-10 | Stage IV treatment: Systemic chemotherapy + endocrine therapy for eligible patients | 80% |
| BRC-11 | Treatment all stages | 80% |
| BRC-12 | Optimal program: treatment of all stages plus a breast awareness program and early case finding through biannual mammographic screening in women age 50–70 years. | 80% |
| BRC-13 | Stage I treatment: Lumpectomy with auxiliary dissection + radiotherapy to the breast + endocrine therapy where applicable | 95% |
| BRC-14 | Stage II treatment: Lumpectomy with auxiliary dissection + radiotherapy to the breast + endocrine therapy where applicable | 95% |
| BRC-15 | Stage III treatment: Neo-adjuvant chemotherapy + mastectomy with auxiliary dissection + adjuvant chemotherapy + endocrine therapy where applicable | 95% |
| BRC-16 | Stage IV treatment: Systemic chemotherapy + endocrine therapy for eligible patients | 95% |
| BRC-17 | Treatment all stages | 95% |
| BRC-18 | Optimal program: treatment of all stages plus a breast awareness program and early case finding through biannual mammographic screening in women age 50–70 years. | 95% |